Open AccessEfficacy of weekly paclitaxel for the treatment of advanced ovarian cancer
Author(s) -
Dong-Xu Zhao,
Ping Chen,
Cui-Hong Su,
Yanyan Zhao,
Lidan Sun,
Hongxuan He,
Xiaona Feng
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000020537
Subject(s) - medicine , paclitaxel , ovarian cancer , oncology , gynecology , medline , cancer , political science , law
Background: This study aims to assess the efficacy and safety of weekly paclitaxel (WP) for the treatment of advanced ovarian cancer (AOC). Methods: This study will systematically search bibliographic databases (MEDLINE, EMBASE, Cochrane Library, Web of Science, CINAHL, PSYCINFO, Allied and Complementary Medicine Database, CNKI, WANGFANG, and Chinese Biomedical Literature Database) and other literature sources from inception to the March 1, 2020 without language and publication time limitations. Two authors will independently complete all literature selection, data collection, and study quality evaluation. Any disagreements will be solved by a third author through discussion. We will analyze data by RevMan V.5.3 software. Results: This study will systematically generate a comprehensive summary on the efficacy and safety of WP for the treatment of AOC. Conclusion: This study may provide beneficial evidence of WP for the treatment of AOC. Systematic review registration: INPLASY202040193.